Three-year follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, for second-line (2L) treatment of non-small cell lung cancer (NSCLC)

Paz-Ares, L.Kim, T. M.Vicente, D.Felip, E.Lee, D. H.Lee, K. H.Lin, C-C.Flor, M. J.Di Nicola, M.Alvarez, R. M.Helwig, C.Ojalvo, L. S.Gulley, J.Cho, B. C.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/27552enThree-year follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, for second-line (2L) treatment of non-small cell lung cancer (NSCLC)conference outputopen access10.1016/j.annonc.2020.08.15861569-8041http://www.annalsofoncology.org/article/S0923753420415820/pdf573469101558